The HMRI Cancer Program draws together 131 researchers and 21 research students from the University of Newcastle, Hunter New England Health and Calvary Mater Newcastle.
The Cancer Program, led by Clinical Professor Steven Ackland from Calvary Mater Newcastle and Professor Leonie Ashman from the University of Newcastle, brings together biomedical, clinical and public health researchers focused on four key malignancies:
- Breast Cancer
- Prostate Cancer
- Melanoma
- Haematological malignancies
The Program also incorporates four clinical trials groups, based in the Hunter:
- Australia New Zealand Breast Cancer Trials Group (ANZBCTG)
- Trans-Tasman Radiation Oncology Group (TROG)
- Prostate Cancer Trials Group (PCTG)
- Newcastle Melanoma Unit
The Cancer Program is centred on the key themes of Cellular and Molecular Oncology, Psycho-oncology, and Clinical and Translational Oncology.
From understanding the biology of cancer and developing more effective cancer therapies, evaluating therapies in clinical trials, and developing better models of care and support for cancer patients and carers, Hunter researchers are aiming to reduce the impact of cancer in our community, and globally.
The Cancer Program draws on many strong collaborations with the HMRI Information Based Medicine and Public Health Programs, guiding the translation from knowledge to a clinical focus on prevention, specific and novel therapies, and evaluation of patient responses to existing and emerging therapies.
